Isorhynchophylline, a natural alkaloid, promotes the degradation of alpha-synuclein in neuronal cells via inducing autophagy - PubMed (original) (raw)
Isorhynchophylline, a natural alkaloid, promotes the degradation of alpha-synuclein in neuronal cells via inducing autophagy
Jia-Hong Lu et al. Autophagy. 2012 Jan.
Erratum in
- Autophagy. 2012 May 1;8(5):864-6
Abstract
Accumulation of α-synuclein (α-syn) in the brain is a pathogenic feature and also a causative factor of Parkinson disease. Isorhynchophylline (IsoRhy) is a major tetracyclic oxindole alkaloid isolated from the Chinese herbal medicine Uncaria rhynchophylla (Miq.)Jacks (Gouteng in Chinese), which has been used for the treatment of neurological diseases in East Asia for centuries. Here we report a novel function of IsoRhy as a neuronal autophagy inducer. IsoRhy induced autophagy in different neuronal cell lines, including N2a, SH-SY5Y and PC12 cells, and also in primary cortical neurons. Furthermore, IsoRhy induced autophagy in the fat bodies of Drosophila. IsoRhy promoted clearance of wild-type, A53T and A30P α-syn monomers, α-syn oligomers and α-syn/synphilin-1 aggresomes in neuronal cells via the autophagy-lysosome pathway. More importantly, IsoRhy was able to decrease the expression levels of wild-type and A53T α-syn protein in differentiated human dopaminergic neurons. Notably, IsoRhy-induced autophagy was independent of the mTOR pathway but dependent on the function of Beclin 1. Taken together, data from this study raise the possibility that oxindole alkaloid derivatives may serve as a means to stimulate autophagy in neuronal cells, thereby exerting preventive and therapeutic values against neurodegenerative diseases such as Parkinson disease by reducing pathogenic protein aggregates in neurons.
Similar articles
- Corynoxine, a natural autophagy enhancer, promotes the clearance of alpha-synuclein via Akt/mTOR pathway.
Chen LL, Song JX, Lu JH, Yuan ZW, Liu LF, Durairajan SS, Li M. Chen LL, et al. J Neuroimmune Pharmacol. 2014 Jun;9(3):380-7. doi: 10.1007/s11481-014-9528-2. Epub 2014 Feb 13. J Neuroimmune Pharmacol. 2014. PMID: 24522518 - Triptolide Promotes the Clearance of α-Synuclein by Enhancing Autophagy in Neuronal Cells.
Hu G, Gong X, Wang L, Liu M, Liu Y, Fu X, Wang W, Zhang T, Wang X. Hu G, et al. Mol Neurobiol. 2017 Apr;54(3):2361-2372. doi: 10.1007/s12035-016-9808-3. Epub 2016 Mar 9. Mol Neurobiol. 2017. PMID: 26957304 - Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
Zhu Q, Zhuang XX, Chen JY, Yuan NN, Chen Y, Cai CZ, Tan JQ, Su HX, Lu JH. Zhu Q, et al. Phytomedicine. 2021 Jul;87:153578. doi: 10.1016/j.phymed.2021.153578. Epub 2021 Apr 27. Phytomedicine. 2021. PMID: 34038839 - Autophagy in Neurodegenerative Diseases: A Hunter for Aggregates.
Park H, Kang JH, Lee S. Park H, et al. Int J Mol Sci. 2020 May 10;21(9):3369. doi: 10.3390/ijms21093369. Int J Mol Sci. 2020. PMID: 32397599 Free PMC article. Review. - Isorhynchophylline: A plant alkaloid with therapeutic potential for cardiovascular and central nervous system diseases.
Zhou JY, Zhou SW. Zhou JY, et al. Fitoterapia. 2012 Jun;83(4):617-26. doi: 10.1016/j.fitote.2012.02.010. Epub 2012 Mar 2. Fitoterapia. 2012. PMID: 22406453 Review.
Cited by
- α-Synuclein oligomers and clinical implications for Parkinson disease.
Kalia LV, Kalia SK, McLean PJ, Lozano AM, Lang AE. Kalia LV, et al. Ann Neurol. 2013 Feb;73(2):155-69. doi: 10.1002/ana.23746. Epub 2012 Dec 7. Ann Neurol. 2013. PMID: 23225525 Free PMC article. Review. - Corynoxine B derivative CB6 prevents Parkinsonian toxicity in mice by inducing PIK3C3 complex-dependent autophagy.
Zhu Z, Liu LF, Su CF, Liu J, Tong BC, Iyaswamy A, Krishnamoorthi S, Sreenivasmurthy SG, Guan XJ, Kan YX, Xie WJ, Zhao CL, Cheung KH, Lu JH, Tan JQ, Zhang HJ, Song JX, Li M. Zhu Z, et al. Acta Pharmacol Sin. 2022 Oct;43(10):2511-2526. doi: 10.1038/s41401-022-00871-0. Epub 2022 Feb 25. Acta Pharmacol Sin. 2022. PMID: 35217810 Free PMC article. - The Autophagy Signaling Pathway: A Potential Multifunctional Therapeutic Target of Curcumin in Neurological and Neuromuscular Diseases.
Perrone L, Squillaro T, Napolitano F, Terracciano C, Sampaolo S, Melone MAB. Perrone L, et al. Nutrients. 2019 Aug 13;11(8):1881. doi: 10.3390/nu11081881. Nutrients. 2019. PMID: 31412596 Free PMC article. Review. - Impairment of the autophagy-lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential.
Zhang W, Xu C, Sun J, Shen HM, Wang J, Yang C. Zhang W, et al. Acta Pharm Sin B. 2022 Mar;12(3):1019-1040. doi: 10.1016/j.apsb.2022.01.008. Epub 2022 Jan 21. Acta Pharm Sin B. 2022. PMID: 35530153 Free PMC article. Review. - Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson's Disease.
Bonam SR, Tranchant C, Muller S. Bonam SR, et al. Cells. 2021 Dec 15;10(12):3547. doi: 10.3390/cells10123547. Cells. 2021. PMID: 34944054 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous